Phytochemical investigation of natural and in vitro raised Vṛddhadāruka plants

Evaluation of the Anticancer Properties of Geranyl Isovalerate, an Active Ingredient of Argyreia nervosa Extract in Colorectal Cancer Cells

Chemotherapy is a general treatment procedure for cancer. The diversity in cancer incidence and the failure of therapy due to chemoresistance lead to increased cancer-related deaths. Therefore, new drugs with fewer secondary complications targeting diverse pathways are the need of the hour. Geranyl isovalerate (GIV), one of the active ingredients of ethyl acetate fraction of Argyreia nervosa is routinely used as a food flavoring agent. In this study, we found that GIV also exhibits anticancer activity when tested against the HCT116 cell line. It influenced the viability of the cells in a dose- and time-dependent manner. We examined whether GIV could induce oxidative stress and affect the mitochondrial membrane potential, thereby leading to apoptosis induction. Moreover, GIV could suppress the expression of antiapoptotic genes, such as BCl2 and PARP, and induce the expression of proapoptotic genes, such as Caspase 3 and 9. This is the first study demonstrating the anticancer activity of GIV and providing evidence for its mechanism of action. In conclusion, this study proposes GIV as a potential lead or supplementary molecule in treating and preventing colorectal cancer (CRC). Based on our findings, we conclude that GIV may be a viable lead or supplementary molecule for treating and preventing CRC.

Bioinspired triangular ZnO nanoclusters synthesized by Argyreia nervosa nascent leaf extract for the efficient electrochemical determination of vitamin C

This work deals with the synthesis of bioinspired triangular ZnO nanoclusters (bT-ZnO NCs) from Argyreia nervosa nascent leaf extract for their effective antibacterial activity and further utilization as a platform for the electrocatalytic determination of ascorbic acid (AA; vitamin C) for applications in the agricultural domain. The structural, optical, and morphological characteristics of the synthesized bT-ZnO NCs were analyzed by UV-vis, FT-IR, XRD, AFM, SEM, TEM, HR-TEM, and EDX techniques. After this, bT-ZnO NCs were electrophoretically deposited onto an indium-tin-oxide (ITO) glass substrate and assessed for the electro-oxidation of AA by cyclic voltammetry (CV), and from this it was proven that bT-ZnO NCs had a very high electrochemical sensitivity of 29.88 μA cm⁻² toward AA and a low limit of detection of 0.5321 mM under the optimized experimental conditions. Thus, it provides a potential sensing platform for electrochemical studies to detect AA. Moreover, bT-ZnO NCs were preliminarily investigated for their antibacterial activity, and the obtained results showed that the bT-ZnO NCs have potency as an antibacterial agent.

This study reports the synthesis of bioinspired triangular ZnO nanoclusters (bT-ZnO NCs) from Argyreia nervosa nascent leaf extract and their use in the agricultural domain for the label-free detection of vitamin C and its antibacterial efficiency.

Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c

Nonalcoholic fatty liver disease (NAFLD) refers to a pathological condition of hepatic steatosis. Insulin resistance is believed to be the key mechanism mediating initial accumulation of fat in the liver, resulting in hepatic steatosis. Kukoamine A (KuA), a spermine alkaloid, is a major bioactive component extracted from the root barks of Lycium chinense (L. chinense) Miller. In the current study, we aimed to explore the possible effect of KuA on insulin resistance and fatty liver. We showed that KuA significantly inhibited the increase of fasting blood glucose level and insulin level, and the glucose levels in response to glucose and insulin load in HFD-fed mice, which was in a dose-dependent manner. KuA dose-dependently decreased the histological injury of liver, levels of hepatic triglyceride (TG), and serum AST and ALT activities in HFD-fed mice. The increase of serum levels of TNFɑ, IL-1β, IL-6 and C reactive protein in HFD-fed mice was inhibited by KuA. HFD feeding-induced increase of hepatic expression of Srebp-1c and its target genes, including fatty acid synthase (FAS) and acetyl CoA carboxylase 1 (ACC1), was significantly inhibited by KuA. Moreover, upregulation of Srebp-1c notably inhibited KuA-induced improvement of insulin-stimulated glucose uptake, decrease of lipid accumulation and H₂O₂ level in palmitic acid-treated AML-12 cells. In conclusion, we reported that KuA inhibited Srebp-1c and downstream genes expression and resulted in inhibition of lipid accumulation, inflammation, insulin resistance and oxidative stress. Overall, our results provide a better understanding of the pharmacological activities of KuA against insulin resistance and hepatic steatosis.